FIDSX
Price
$15.95
Change
-$0.08 (-0.50%)
Updated
Jul 8 closing price
Net Assets
1.09B
FRBAX
Price
$29.92
Change
+$0.14 (+0.47%)
Updated
Jul 8 closing price
Net Assets
852.6M
Interact to see
Advertisement

FIDSX vs FRBAX

Header iconFIDSX vs FRBAX Comparison
Open Charts FIDSX vs FRBAXBanner chart's image
Fidelity Select Financials Port
Price$15.95
Change-$0.08 (-0.50%)
VolumeN/A
Net Assets1.09B
JHancock Regional Bank A
Price$29.92
Change+$0.14 (+0.47%)
VolumeN/A
Net Assets852.6M
FIDSX vs FRBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FIDSX vs. FRBAX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIDSX is a StrongBuy and FRBAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FIDSX has more cash in the bank: 1.09B vs. FRBAX (853M). FRBAX pays higher dividends than FIDSX: FRBAX (1.73) vs FIDSX (1.36). FIDSX was incepted earlier than FRBAX: FIDSX (44 years) vs FRBAX (34 years). FRBAX (1.27) is less costly to investors than FIDSX (0.69). FIDSX is a more actively managed with annual turnover of: 35.00 vs. FRBAX (3.00). FIDSX has a lower initial minimum investment than FRBAX: FIDSX (0) vs FRBAX (1000). FIDSX (25.90) and FRBAX (25.42) have marching annual gain over last year. FIDSX return over 5 years is better than : 134.96 vs. FRBAX (96.03).
FIDSXFRBAXFIDSX / FRBAX
Total Expense Ratio0.691.2655%
Annual Report Gross Expense Ratio0.691.2754%
Fund Existence44 years34 years-
Gain YTD7.7375.266147%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B853M127%
Annual Yield % from dividends1.361.7379%
Returns for 1 year25.9025.42102%
Returns for 3 years59.7714.76405%
Returns for 5 years134.9696.03141%
Returns for 10 years97.4065.30149%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.05N/A
+5.05%
Oncotelic Therapeutics, Inc.
SVYSF34.620.62
+1.84%
Solvay S.A.
NPPNY5.33N/A
N/A
Nippon Shinyaku Co. Ltd.
IHRTB0.71N/A
N/A
iHeartMedia, Inc.
PMMBF16.65N/A
N/A
Pembina Pipeline Corp.